V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 160013063 | 160015557 | 1.81 | 50.25 | null | 2018-10-11 | 2018-10-11 | DOXORUBICIN | 02 | null | DOXORUBICIN | 100049338 |
| 160013066 | 160015558 | 1.6 | 76 | Palliative (P) | 2021-04-07 | 2021-04-29 | DOXORUBICIN | 02 | N | DOXORUBICIN | 101369235 |
| 160013070 | 160015559 | 1.81 | 103.8 | null | 2018-09-14 | 2018-09-14 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100121825 |
| 160013071 | 160015560 | 1.89 | 68.8 | Palliative (P) | 2022-01-26 | 2022-02-09 | DOXORUBICIN | 02 | N | TRIAL UNSPECIFIED | 101799854 |
| 160013076 | 160015561 | 1.77 | 66 | null | 2020-12-18 | 2021-01-11 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101083235 |
| 160013079 | 160015562 | 1.63 | 84.75 | null | null | null | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101128152 |
| 160013080 | 160015563 | 1.75 | 83.6 | null | 2019-04-27 | 2019-05-01 | NIVOLUMAB | 02 | null | NIVOLUMAB | 100033727 |
| 160013089 | 160015564 | 0 | 140 | null | 2019-03-16 | 2019-03-16 | Trial Unspecified | 01 | null | TRIAL UNSPECIFIED | 101654417 |
| 160013092 | 160015565 | 1.67 | 80.6 | Palliative (P) | 2020-12-17 | 2020-12-17 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100005324 |
| 160013099 | 160015566 | 1.56 | 77.2 | null | 2019-11-14 | 2019-12-20 | VINORELBINE | N | null | VINORELBINE | 100073797 |
| 160013104 | 160015567 | 1.79 | 97.7 | Palliative (P) | 2021-11-18 | 2021-11-28 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100894127 |
| 160013115 | 160015568 | 1.68 | 95.5 | null | 2021-03-09 | 2021-03-09 | Doxorubicin 75mg/m2 | 02 | null | TRABECTEDIN | 101106552 |
| 160013117 | 160015569 | 1.65 | 77 | Palliative (P) | 2018-07-07 | 2018-07-08 | Doxorubicin 75mg/m2 | 02 | N | VINORELBINE | 101501212 |
| 160013130 | 160015570 | 1.63 | 61.7 | Palliative (P) | 2020-03-20 | 2020-03-23 | Trial Unspecified | 02 | N | TRIAL UNSPECIFIED | 101258472 |
| 160013138 | 160015571 | 1.81 | 80 | Palliative (P) | 2020-10-10 | 2020-10-20 | Doxorubicin 75mg/m2 | N | N | DOXORUBICIN | 100742478 |
| 160013142 | 160015572 | 1.87 | 68.7 | null | 2016-11-06 | 2016-11-13 | Trabectedin | 02 | null | TRABECTEDIN | 101650471 |
| 160013147 | 160015573 | 1.6 | 71.8 | Palliative (P) | 2021-09-03 | 2021-09-04 | Doxorubicin 75mg/m2 | null | null | TRABECTEDIN | 101492159 |
| 160013151 | 160015574 | 1.75 | 93.3 | 03 | 2018-09-21 | 2018-10-24 | DOXORUBICIN | 02 | N | DOXORUBICIN | 100148113 |
| 160013154 | 160015575 | null | 70.4 | Palliative (P) | 2022-03-09 | 2022-03-15 | Doxorubicin 75mg/m2 | 02 | null | TRIAL UNSPECIFIED | 100790945 |
| 160013159 | 160015576 | null | 74.6 | Palliative (P) | 2019-10-01 | 2020-01-29 | Doxorubicin 75mg/m2 | 02 | N | DOXORUBICIN | 100321768 |
| 160013164 | 160015577 | 1.77 | 89.7 | Palliative (P) | 2021-02-22 | 2021-03-17 | Trabectedin | 02 | N | TRABECTEDIN | 101390078 |
| 160013165 | 160015578 | 1.68 | 54.3 | null | 2019-10-08 | 2019-12-26 | Doxorubicin 75mg/m2 | 02 | null | DOXORUBICIN | 100669732 |
| 160013168 | 160015579 | 1.69 | 94.2 | Palliative (P) | 2022-01-20 | 2022-02-05 | Trabectedin | 02 | null | TRABECTEDIN | 101535655 |
| 160013170 | 160015580 | 1.82 | null | null | 2020-10-04 | 2021-08-31 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101105574 |
| 160013172 | 160015581 | 1.81 | 54.35 | Palliative (P) | 2020-06-12 | 2021-06-04 | Vinorelbine (oral) | 02 | N | VINORELBINE | 100708011 |
| 160013173 | 160015582 | 1.65 | 63.4 | Palliative (P) | 2020-05-14 | 2020-05-22 | Trial Unspecified | 01 | N | TRIAL UNSPECIFIED | 100863842 |
| 160013174 | 160015583 | 1.59 | 61.3 | null | 2017-05-01 | 2017-06-05 | Doxorubin 50mg/m2 | 02 | null | DOXORUBICIN | 100806418 |
| 160013179 | 160015584 | 1.54 | 67.7 | Palliative (P) | 2022-03-31 | 2022-03-31 | Trabectedin | 02 | N | TRABECTEDIN | 100151591 |
| 160013180 | 160015585 | 1.9 | 90.2 | Palliative (P) | 2022-01-04 | 2022-02-03 | VINORELBINE | 02 | N | VINORELBINE | 100508139 |
| 160013189 | 160015586 | 1.65 | 63.4 | null | 2017-08-25 | 2017-09-11 | NIVOLUMAB | 02 | null | NIVOLUMAB | 101719448 |
| 160013190 | 160015587 | 1.77 | 75.3 | Palliative (P) | 2017-12-22 | 2017-12-26 | Doxorubicin 75mg/m2 | 02 | N | VINORELBINE | 100645166 |
| 160013194 | 160015589 | 1.76 | 72.2 | Palliative (P) | 2017-05-12 | 2017-05-28 | Bevacizumab | 02 | null | DOXORUBICIN + OLARATUMAB | 100674482 |
| 160013195 | 160015590 | 1.59 | 70.4 | null | 2016-12-10 | 2016-12-16 | Liposomal Doxorubicin 40mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 101200734 |
| 160013205 | 160015591 | 1.71 | 63.1 | null | 2017-08-05 | 2017-08-19 | CARBOPLATIN + PACLITAXEL | 02 | null | CARBOPLATIN + PACLITAXEL | 100730350 |
| 160013206 | 160015592 | 1.77 | 96.3 | Palliative (P) | 2020-08-07 | 2020-08-21 | Bevacizumab 7.5mg/kg | null | null | BEVACIZUMAB | 100535539 |
| 160013210 | 160015594 | 1.55 | 139 | Adjuvant (A) | 2018-07-22 | 2018-12-04 | Cisplatin + Pemetrexed | 02 | N | CISPLATIN + PEMETREXED | 100621302 |
| 160013214 | 160015595 | 1.8 | 71.1 | null | 2019-08-22 | 2019-09-07 | Liposomal Doxorubicin (Caelyx) | 02 | null | LIPOSOMAL DOXORUBICIN | 100457641 |
| 160013215 | 160015596 | 1.76 | 74.75 | 03 | 2021-06-17 | 2021-07-22 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN | 100845242 |
| 160013216 | 160015597 | 1.78 | 70.7 | null | 2018-08-20 | 2018-08-20 | Bevacizumab 7.5mg/kg | null | null | BEVACIZUMAB | 100940128 |
| 160013220 | 160015598 | 1.63 | 75.4 | null | null | null | Bevacizumab 7.5mg/kg | null | null | CARBOPLATIN + GEMCITABINE | 101281478 |
| 160013224 | 160015599 | 1.83 | 0 | Palliative (P) | 2017-12-21 | 2017-12-21 | Bevacizumab 7.5mg/kg | 02 | N | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 100688571 |
| 160013230 | 160015600 | 1.61 | 103.2 | Palliative (P) | 2017-07-03 | 2017-07-04 | Bevacizumab | 02 | N | CARBOPLATIN + PACLITAXEL | 100316109 |
| 160013244 | 160015601 | 1.79 | 66.2 | Palliative (P) | 2019-02-08 | 2019-02-09 | CARBOPLATIN + PACLITAXEL | 02 | N | CARBOPLATIN + PACLITAXEL | 101799097 |
| 160013245 | 160015602 | 1.88 | 55 | Palliative (P) | 2022-04-26 | 2022-05-12 | GemCarbo Days 1+8 | N | N | CARBOPLATIN + GEMCITABINE | 100934321 |
| 160013256 | 160015603 | 1.65 | 63.7 | Palliative (P) | null | 2019-05-13 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | CISPLATIN + PEMETREXED | 101670964 |
| 160013259 | 160015604 | 1.57 | 63.35 | 03 | 2021-04-07 | 2021-04-23 | Liposomal Doxorubicin (Caelyx) | N | N | LIPOSOMAL DOXORUBICIN | 100750835 |
| 160013261 | 160015605 | 1.78 | 64.1 | Palliative (P) | 2019-08-10 | 2019-08-20 | Liposomal Doxorubicin 50mg/m2 | 02 | N | LIPOSOMAL DOXORUBICIN | 100678453 |
| 160013268 | 160015606 | 1.84 | 68 | Palliative (P) | null | 2019-10-26 | Liposomal Doxorubicin (Caelyx) | 02 | N | LIPOSOMAL DOXORUBICIN | 101515380 |
| 160013269 | 160015607 | 1.94 | 70.5 | Palliative (P) | 2018-05-20 | 2018-05-20 | Carboplatin AUC 6 - 10 | 02 | N | CARBOPLATIN | 101807407 |
| 160013271 | 160015608 | 1.79 | 58.1 | null | 2017-10-12 | 2017-10-27 | Bevacizumab 7.5mg/kg | null | null | CARBOPLATIN + LIPOSOMAL DOXORUBICIN | 101117579 |